AR106180A2 - A-AMINOCARBOXYAMIDE COMPOUND THAT IS 5- (4 - {[(2-FLUOROPHENYL) METHYL] OXI} PHENYL) PROLINAMIDE - Google Patents
A-AMINOCARBOXYAMIDE COMPOUND THAT IS 5- (4 - {[(2-FLUOROPHENYL) METHYL] OXI} PHENYL) PROLINAMIDEInfo
- Publication number
- AR106180A2 AR106180A2 ARP160102963A ARP160102963A AR106180A2 AR 106180 A2 AR106180 A2 AR 106180A2 AR P160102963 A ARP160102963 A AR P160102963A AR P160102963 A ARP160102963 A AR P160102963A AR 106180 A2 AR106180 A2 AR 106180A2
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- prolinamide
- fluorophenyl
- phenyl
- methyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compuesto de a-aminocarboxiamida que es 5-(4-{[(2-fluorofenil)metil]oxi}fenil)prolinamida de fórmula (1), ó un compuesto de fórmula (2), o su sal farmacéuticamente aceptable, solvato o profármaco, como ser el hidrocloruro. Dicho compuesto en forma cristalina. Composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento para tratar o prevenir una enfermedad o trastorno mediados por la modulación de los canales de sodio con apertura por voltaje (“voltage-gated”), dependientes del uso, como ser depresión o trastorno del estado emocional, trastorno bipolar o relacionado con sustancias. Proceso para preparar dicho compuesto.A-aminocarboxamide compound which is 5- (4 - {[(2-fluorophenyl) methyl] oxy} phenyl) prolinamide of formula (1), or a compound of formula (2), or its pharmaceutically acceptable salt, solvate or prodrug , such as hydrochloride. Said compound in crystalline form. Pharmaceutical composition that comprises it and its use for the manufacture of a medicine to treat or prevent a disease or disorder mediated by the modulation of the voltage-gated sodium channels, depending on the use, such as depression or emotional state disorder, bipolar or substance-related disorder. Process to prepare said compound.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0520581A GB0520581D0 (en) | 2005-10-10 | 2005-10-10 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR106180A2 true AR106180A2 (en) | 2017-12-20 |
Family
ID=35430120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160102963A AR106180A2 (en) | 2005-10-10 | 2016-09-28 | A-AMINOCARBOXYAMIDE COMPOUND THAT IS 5- (4 - {[(2-FLUOROPHENYL) METHYL] OXI} PHENYL) PROLINAMIDE |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN101326163B (en) |
AR (1) | AR106180A2 (en) |
GB (1) | GB0520581D0 (en) |
UA (1) | UA93887C2 (en) |
ZA (1) | ZA200802879B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201139406A (en) * | 2010-01-14 | 2011-11-16 | Glaxo Group Ltd | Voltage-gated sodium channel blockers |
US9676757B2 (en) * | 2014-02-27 | 2017-06-13 | Merck Patent Gmbh | Heterocyclic compounds as NaV channel inhibitors and uses thereof |
CN112812048B (en) * | 2021-01-20 | 2022-08-26 | 北京蓝博特科技有限公司 | Preparation method of sodium ion channel retarder CNV1014802 hydrochloride form |
-
2005
- 2005-10-10 GB GB0520581A patent/GB0520581D0/en not_active Ceased
-
2006
- 2006-10-06 UA UAA200804637A patent/UA93887C2/en unknown
- 2006-10-06 CN CN2006800463149A patent/CN101326163B/en active Active
-
2008
- 2008-04-02 ZA ZA200802879A patent/ZA200802879B/en unknown
-
2016
- 2016-09-28 AR ARP160102963A patent/AR106180A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UA93887C2 (en) | 2011-03-25 |
CN101326163B (en) | 2011-03-09 |
CN101326163A (en) | 2008-12-17 |
GB0520581D0 (en) | 2005-11-16 |
ZA200802879B (en) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR056575A1 (en) | COMPOSITE OF (ALPHA) -AMINOCARBOXYAMIDE THAT IS 5- (4 - [[(2-FLUOROPHENYL) METHYL] OXI] PHENYL) PROLINAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE IT | |
AR053162A1 (en) | COMPOUND 5 - OXO - REPLACED PIRROLIDIN, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA. | |
AR047992A1 (en) | DIAMINOPIRIMIDINS AS ANTAGONISTS OF P2X3 AND P2X2 / 3 | |
GT200600163A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
CO5640076A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDED BY AN IBAT INHIBITOR FOR THE TREATMENT OR PROFILAXIS OF THE CONSTIPATION | |
CO6160236A2 (en) | QUINASE INHIBITOR | |
ECSP055867A (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
AR048336A1 (en) | HYDROCLORIDE OF (4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL) - (4-BROMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE | |
ECSP055774A (en) | NEW MEDICATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | |
NZ592425A (en) | Isoindoline compounds for use in the treatment of cancer | |
ECSP066312A (en) | PIRIDILO DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | |
CL2011000589A1 (en) | Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer. | |
DE602004008098D1 (en) | SUBSTITUTED 2H-Ä1,2,4ÜTRIAZOLOÄ4,3-AÜPYRAZINE AS GSK-3 INHIBITORS | |
AR058780A1 (en) | IMIDAZOPIRAZINAS AS INHIBITORS OF CYCLINE-DEPENDENT KINASES | |
EA200900155A1 (en) | MODULATORS OF PHARMACOKINETIC PROPERTIES OF MEDICINES | |
ECSP066950A (en) | ADRENOCEPTOR-BETA2 GLICOPIRROLATE AND AGONIST COMBINATIONS | |
ECSP088973A (en) | IMIDAZOL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE SYNTHETIC KINASE GLYCOGEN (GSK3) | |
DK1689721T3 (en) | Aminopyrazole derivatives as GSK-3 inhibitors | |
ECSP088283A (en) | PIRIDINE COMPOUNDS 5- (PHENYLISOXAZOLILETOXI) -TRIAZOL- 3-ILO SUBSTITUTED FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS | |
AR058293A1 (en) | PROFARMATIC SALTS AND FORMULATIONS OF 1- [5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO [2,3-D] PIRIMIDIN-5-CARBONIL) -2-METOXI-PHENIL] -3- (2,4- DICLOR-PHENYL) | |
UY30426A1 (en) | SUBSTITUTED DERIVATIVES OF 3- (4-METOXI-PHENYL) -3H-ISOINDOL-1-ILLUMIN TRIFLUOROACETATE, ITS SALTS OR SOLVATOS PHARMACEUTICALLY ACCEPTABLE, PHARMACEUTICAL FORMULATIONS AND APPLICATIONS. | |
UY29085A1 (en) | PIRIMIDINE DERIVATIVES 4-SULFONAMID SUBSTITUTED, INTERMEDIATE COMPOUNDS FOR PREPARATION, PREPARATION PROCEDURES, MEDICINAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
EA201000643A1 (en) | SUBSTITUTED PRODUCTION OF ETHYLENEDIAMIN FOR THE TREATMENT OF MYCOBACTERIAL DISEASES AND PHARMACEUTICAL COMPOSITION ON ITS BASIS | |
CL2009000241A1 (en) | Compounds derived from 5- (2-morpholin-4-yl-7h-pyrrolo [2,3-d] pyrimidin-4-yl) pyrimidin-2-ylamine; Preparation process; pharmaceutical composition; and use of the compounds to treat or prevent a proliferative disease such as cancer. | |
ECSP088099A (en) | NEW DERIVATIVES OF 2-AZETIDINONE FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |